After losing the bid – Novo Nordisk takes off
This weekend's news that Danish Novo Nordisk is losing the bidding war for the pharmaceutical company Metsera is causing the stock to rise.
BusinessTop news
Novo Nordisk loses bidding war against Pfizer
Danish pharmaceutical giant Novo Nordisk is losing the tumultuous bidding war against competitor Pfizer to take over the pharmaceutical company Metsera. The deal is worth ten billion dollars, equivalent to just over 95 billion kronor.
Business
Pfizer raises forecast
American pharmaceutical giant Pfizer is raising its profit forecast for 2025 for the second time this year.
Business